Does Injection Number Matter? A Systematic Review and Meta-Analysis of Bladder Botox for Overactive Bladder
International Urogynecology Journal · 21.08.2026
DOI: 10.1007/s00192-026-06848-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Urogynecology Journal, online erschienen am 21.08.2026. Verfasst von Brittany L Roberts und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Urogynecology, University of Chicago, Chicago, IL, USA. brittanylrobertsmd@gmail.com. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction and Hypothesis Intravesical onabotulinumtoxin-A (BoNT-A) is an established treatment for overactive bladder (OAB). Although the FDA-approved standard regimen involves 20-injections, evidence suggests fewer injections may achieve comparable outcomes.
Objectives
To systematically review studies comparing periprocedural outcomes of reduced-injection versus standard 20-injection BoNT-A techniques for OAB. Study Design PubMed, Scopus, and Embase were searched from their inception through 6/11/2026. Eligible studies included women undergoing in-office bladder BoNT-A (100 U) for OAB. The intervention was a reduced number of injections and the comparator was the 20-injection protocol. Outcomes included efficacy, pain during injection, urinary tract infections (UTI), and retention. Abstracts and full-text articles were doubly screened; accepted articles were doubly extracted. Study quality was assessed using GRADE criteria, ROB2, and ROBIN-I. Random-effects meta-analyses were performed to pool proportions and risk ratios.
Results
We screened 4066 abstracts, 139 full-text papers were assessed, leaving 16 studies (eight RCTs and three retrospective cohort studies, four prospective cohort study, and one case series) with 1393 patients. Most outcomes were supported by low- to high-quality evidence. Mean follow-up was 8.7 ± 4.3 weeks, and the reduced-injection groups received a mean of 7.3 ± 2.8 injection sites. Meta-analysis demonstrated no difference in efficacy between reduced- and standard-injection protocols (79% (95% CI 0.66–0.89); p = 0.16). Pain scores were not different between the reduced-injection group and the standard-injection group (mean difference 0 (95% CI 0.36–0.34); p = 0.23)). UTI (16% (95% CI 0.12–0.21); p = 0.427) and urinary retention (4% (95% CI 0.02–0.06); p = 0.591) adverse events did not vary between groups.
Conclusions
Reduced-injection BoNT-A regimens provide efficacy and safety comparable to the 20-injection protocol, supporting a simplified approach to OAB treatment without compromising outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Urogynecology, University of Chicago, Chicago, IL, USA. brittanylrobertsmd@gmail.com.
- Department of Public Health, School of Health Sciences and Practice, New York Medical College, Hawthorne, NY, USA.
- Department of Obstetrics and Gynecology, Division of Urogynecology, Albany Medical Center, Albany, NY, USA.
Zitieren
APA
Roberts, B. L., Shah, P. S., Carlton, C. E., Leong, K. A., Suarez, B., Kissel, D., Kehoe, S., Uttaro, E., Tepper, K., Drugge, E., Jacobs, B. E., Rogers, R. G., & Grimes, C. L. (2026). Does Injection Number Matter? A Systematic Review and Meta-Analysis of Bladder Botox for Overactive Bladder. International Urogynecology Journal. https://doi.org/10.1007/s00192-026-06848-5
Vancouver
Roberts BL, Shah PS, Carlton CE, Leong KA, Suarez B, Kissel D, et al. Does Injection Number Matter? A Systematic Review and Meta-Analysis of Bladder Botox for Overactive Bladder. International Urogynecology Journal. 2026. doi:10.1007/s00192-026-06848-5
BibTeX
@article{Roberts2026,
author = {Roberts, Brittany L and Shah, Pal Sudhirkumar and Carlton, Caitlin E and Leong, Karissa A and Suarez, Brittany and Kissel, Dara and Kehoe, Sydney and Uttaro, Elena and Tepper, Katherine and Drugge, Elizabeth and Jacobs, Bradley E and Rogers, Rebecca G and Grimes, Cara L},
title = {Does Injection Number Matter? A Systematic Review and Meta-Analysis of Bladder Botox for Overactive Bladder},
journal = {International Urogynecology Journal},
year = {2026},
doi = {10.1007/s00192-026-06848-5}
}
EUVIMED